Published 3 June 2009, doi:10.1136/bmj.b1159
Cite this as: BMJ 2009;338:b1159

Editorials

Treatment of enteric fever

Fluoroquinolones remain the best option in areas where resistance is uncommon

The first 150 words of the full text of this article appear below.

Enteric fever (typhoid and paratyphoid), caused by Salmonella enterica serovar Typhi or serovar Paratyphi A, represents a major burden of disease in communities that lack clean water and adequate sanitation. More than 27 million cases of enteric fever occur worldwide each year, with 216 000 deaths.1 Community based studies in Asia have shown a yearly incidence greater than 400/100 000 population in infants and children.2 In developed countries, returning travellers or those visiting friends and relatives in their family’s country of origin are at risk.3 In endemic areas, most patients are treated with oral antibiotics as outpatients, and only those with severe disease need hospital admission. Relapse may complicate the illness, and faecal carriage can become chronic and lead to onward transmission. In the linked systematic review (doi:10.1136/bmj.b1865), Thaver and colleagues compare the effectiveness of fluoroquinolones as firstline agents with that of other antibiotics for treating enteric fever.4

. . . [Full text of this article]

Christopher M Parry, senior lecturer (honorary consultant)1, Nick J Beeching, senior lecturer (honorary consultant)2

1 School of Infection and Host Defence, University of Liverpool, Liverpool L69 3GA, 2 Liverpool School of Tropical Medicine, Liverpool L3 5QA

cmparry@liverpool.ac.uk


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Rapid Responses:

Read all Rapid Responses

Treatment of enteric fever: what, where and don’t forget Paratyphoid fever?
James B Powell
bmj.com, 9 Jun 2009 [Full text]
Carrier state is a major risk for emergence of antimicrobial resistance to typhoidal salmonellae
Hendrik K van Saene, et al.
bmj.com, 25 Nov 2009 [Full text]
Chronic carriage and mucosal health.
Richard G Fiddian-Green
bmj.com, 27 Nov 2009 [Full text]
Access jobs at BMJ Careers
Whats new online at Student BMJ